Posters
« Back
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
EP25778
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Submitted on 15 May 2017

Pete Stecha, Denise Garvin, Jim Hartnett, Frank Fan, Mei Cong and Zhi-jie Jey Cheng
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711
Poster Views: 1,409
View poster »
Poster Abstract
Immunotherapy aims to boost a patient’s own immune system to fight disease. In recent years, a variety of immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of cancer and autoimmune disease.

Here we describe a platform of T cell activation bioassays for the development of CD3 bispecific antibodies and engineered T cell immunotherapies.

Specifically, we developed two bioluminescent reporter-based bioassays to measure T cell activation via CD3 (NFAT-RE) or CD3 + CD28 (IL-2 promoter). These

Corresponding author: richard.somberg@promega.comReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Gram Negative Rod Breast Wound Infections following Post-Cancer Reconstructive Surgery
Donna Mae Pate, John Greene MD

Alterations in Immunophenotype of Autoimmune-prone Hypomorphic RAG-deficient Patients with CID-G/AI Phenotype
Thomas Pennix, Matthew Stowell, Boglarka Ujhazi, Taco Kuijpers, Olajumoke Fadugba, John Sleasman, Benedict Neven, Waleed Al-Herz, Manish Butte, Elisabeth G. Hoyte, Joseph D. Hernandez, Janet S. Chou9, Raif S. Geha, Luigi D. Notarangelo, Eric Meffre, Krisztian Csomos, Jolan E. Walter

Tumor microenvironment analysis provides insights into the activity of CD8 T-cells and their impact on survival
Ashwini Patil, MS1, Nitin Mandloi, MS1, Kiran V. Paul, MS1, Malini Manoharan, PhD1, Priyanka Shah, PhD1 , Sushri Priyadharshini , MS1, Rohit Gupta, PhD1, and Amitabha Chaudhuri, PhD1, Ravi Gupta, PhD1

Hypogammaglobulinemia in a patient with Turner Syndrome (TS) and Celiac Disease
S. Patel MD, F. Tabatabaian MD

Tight Junction Barrier and Clostridium difficile Infection
Trang Nguyen